Scott C. Kachlany
Oprichter bij Actinobac Biomed, Inc.
Profiel
Scott C.
Kachlany is the founder of Actinobac Biomed, Inc. which was founded in 2009.
He holds the title of Chief Scientific Officer at Actinobac Biomed, Inc. Dr. Kachlany's current job is as a Director at Leukovet.
Dr. Kachlany's former job was as an Associate Professor at the University of Medicine & Dentistry of New Jersey.
Dr. Kachlany obtained a doctorate degree from The Trustees of Columbia University in The City of New York in 2001 and an undergraduate degree from Cornell University in 1997.
Actieve functies van Scott C. Kachlany
| Bedrijven | Functie | Begin |
|---|---|---|
Actinobac Biomed, Inc.
 Actinobac Biomed, Inc. Pharmaceuticals: MajorHealth Technology Actinobac Biomed, Inc. operates as a biopharmaceutical company developing therapeutics. It offers therapeutics for indications, including blood cancers, autoimmune, inflammatory diseases and HIV. The company was founded by Scott C. Kachlany in 2009 and is headquartered in Kendall Park, NJ. | Oprichter | 17-07-2009 |
Leukovet
 Leukovet Pharmaceuticals: MajorHealth Technology Leukovet develops peptide-based cancer therapeutics for the treatment of canine lymphoma, leukemia, and other immunological diseases. The company is based in New York, NY. The company was founded in 2019. The CEO is Sonia Gulati. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Scott C. Kachlany
| Bedrijven | Functie | Einde |
|---|---|---|
| University of Medicine & Dentistry of New Jersey | Corporate Officer/Principal | - |
Opleiding van Scott C. Kachlany
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| Cornell University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Actinobac Biomed, Inc.
Actinobac Biomed, Inc. Pharmaceuticals: MajorHealth Technology Actinobac Biomed, Inc. operates as a biopharmaceutical company developing therapeutics. It offers therapeutics for indications, including blood cancers, autoimmune, inflammatory diseases and HIV. The company was founded by Scott C. Kachlany in 2009 and is headquartered in Kendall Park, NJ. | Health Technology |
Leukovet
Leukovet Pharmaceuticals: MajorHealth Technology Leukovet develops peptide-based cancer therapeutics for the treatment of canine lymphoma, leukemia, and other immunological diseases. The company is based in New York, NY. The company was founded in 2019. The CEO is Sonia Gulati. | Health Technology |
